Monitoring the roles of prothrombin activation fragment 1 and 2 (F1+2) in patients with atrial fibrillation receiving rivaroxaban and apixaban, Ueno Ei-ichi, Fujibayashi Kosuke, Sawaguchi Jun, Yasuda Yushi, Takano Shintaro, Fujioka Nakaba, Kawai Yasuyuki, Fujita Harumi, Tanaka Yoshi, Kajinami Kouji, Journal of Thrombosis and Thrombolysis, 50:371-379, Aug. 2020
Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products., M.Watanabe, Y.Kawai, M.Kitayama, H.Akao, A.Motoyama, M.Wakasa , R.Saito, H.Aoki, K.Fujibayashi, T.Tsuchiya, H.Nakanishi, K.Saito, M.Takeuchi, K.Kajinami, Journal of Cardiology, 69:625-631, Apr. 2017
Chronic total occlusions of the right coronary and left anterior descending coronary arteries in a young adult patient with antiphospholipid syndrome, Y.Kawai, M.Kitayama, A.Motoyama, M.Wakasa, R.Saito, H.Aoki, K.Fujibayashi, M.Watanabe, T.Takamura, H.Akao, T.Tsuchiya, K.Kajinami, Journal of Cardiology Cases, 14:46-48, Aug. 2016
Circulating Glutamate and Taurine Levels Are Associated with the Generation of Reactive Oxygen Species in Paroxysmal Atrial Fibrillation, S.Takano, K.Fujibayashi, N.Fujioka, E.Ueno, M.Wakasa, Y.Kawai, K.Kajinami, Disease Markers, 2016:1-7, 2016
Nutri-pharmacogenomics of warfarin anticoagulation therapy : VKORC1 genotype-dependent influence of dietary vitamin K intake, R.Saito, K.Takeda, K.Yamamoto, A.Nakagawa, H.Aoki, K.Fujibayashi, M.Wakasa, A.Motoyama, M.Iwadare, R.Ishida, N.Fujioka, T.Tsuchiya, H.Akao, Y.Kawai, M.Kitayama, K.Kajinami, Journal of thrombosis and thrombolysis., 38:105-114, Jul. 2014
Increased levels of the oxidative stress marker, nitrotyrosine in patients with provocation test-induced coronary vasospasm, K.Tanabe, Y.Kawai, M.Kitayama, H.Akao, R.Ishida, A.Motoyama, M.Wakasa, R.Saito, H.Aoki, K.Fujibayashi, M.Watanabe, T.Tsuchiya, H.Kimura, K.Yoshida, K.Kajinami, Journal of cardiology, 64:86-90, Jan. 2014
